98 related articles for article (PubMed ID: 34903206)
1. Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms.
Guan Q; Chen R; Yan H; Cai H; Guo Y; Li M; Li X; Tong M; Ao L; Li H; Hong G; Guo Z
Oncotarget; 2016 Oct; 7(42):68909-68920. PubMed ID: 27634898
[TBL] [Abstract][Full Text] [Related]
2. Effects of long noncoding RNA on prognosis of oral squamous cell carcinoma: A protocol for systematic review and meta analysis.
Lin Q; Zhang Y; Liu Y; Xu X
Medicine (Baltimore); 2021 Apr; 100(16):e25507. PubMed ID: 33879685
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation of IFI44L as a potential blood biomarker for childhood-onset systemic lupus erythematosus.
Wang J; Dang X; Wu X; Xiang Z; Li Y; Fu Y; Shen T
Pediatr Res; 2024 Mar; ():. PubMed ID: 38514858
[TBL] [Abstract][Full Text] [Related]
4. Early diagnosis of oral squamous cell carcinoma may ensure better prognosis: A case series.
Bramati C; Abati S; Bondi S; Lissoni A; Arrigoni G; Filipello F; Trimarchi M
Clin Case Rep; 2021 Oct; 9(10):e05004. PubMed ID: 34721865
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of SOX2 for chemotherapeutic patients with oral squamous cell carcinoma.
Zhang X; Xu H; Zhou T; Feng X; Chen Q
J Pharm Anal; 2024 Apr; 14(4):100908. PubMed ID: 38634062
[TBL] [Abstract][Full Text] [Related]
6. Identification of qualitative characteristics of immunosuppression in sepsis based on immune-related genes and immune infiltration features.
Zeng N; Jian Z; Xu J; Peng T; Hong G; Xiao F
Heliyon; 2024 Apr; 10(8):e29007. PubMed ID: 38628767
[TBL] [Abstract][Full Text] [Related]
7. Dissection of an impact of VDR and RXRA on the genomic activity of 1,25(OH)
Olszewska AM; Nowak JI; Myszczynski K; Słominski A; Żmijewski MA
Mol Cell Endocrinol; 2024 Mar; 582():112124. PubMed ID: 38123121
[TBL] [Abstract][Full Text] [Related]
8. Identification of Potential Biomarkers Using Integrative Approach: A Case Study of ESCC.
Saikia M; Bhattacharyya DK; Kalita JK
SN Comput Sci; 2023; 4(2):114. PubMed ID: 36573207
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of seven RNA binding protein genes as a prognostic signature in oral cavity squamous cell carcinoma.
Huang Z; Lan T; Wang J; Chen Z; Zhang X
Bioengineered; 2021 Dec; 12(1):7248-7262. PubMed ID: 34585646
[TBL] [Abstract][Full Text] [Related]
10. MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy.
Cheng Y; Chen J; Shi Y; Fang X; Tang Z
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230547
[TBL] [Abstract][Full Text] [Related]
11. The prognostic and clinical significance of IFI44L aberrant downregulation in patients with oral squamous cell carcinoma.
Ou D; Wu Y
BMC Cancer; 2021 Dec; 21(1):1327. PubMed ID: 34903206
[TBL] [Abstract][Full Text] [Related]
12. The integration of differentially expressed genes based on multiple microarray datasets for prediction of the prognosis in oral squamous cell carcinoma.
Zhao Y; Huang J; Chen J
Bioengineered; 2021 Dec; 12(1):3309-3321. PubMed ID: 34224327
[TBL] [Abstract][Full Text] [Related]
13. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
14. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]